Practice Alert
Practice Alert
2021 CDC guidelines on sexually transmitted infections
A higher dose of ceftriaxone is now recommended for gonorrhea. Doxycycline, not azithromycin, is first-line therapy for chlamydia.
Practice Alert
Influenza vaccine update, 2021-22
Give the vaccine by the end of October. The CDC states that COVID-19 vaccines can be co-administered with influenza vaccines, but reactogenicity...
Practice Alert
How to proceed when it comes to vitamin D
USPSTF findings would support screening selective populations at risk for deficiency. But the value of supplements for prevention is nil or still...
Practice Alert
A review of the latest USPSTF recommendations
The Task Force has expanded the age range for screening for hepatitis C virus infection in adolescents and adults, and now endorses behavioral...
Practice Alert
ACIP recommendations for COVID-19 vaccines—and more
Prioritized immunization is advised with the 2 COVID-19 vaccines. A third meningococcal ACWY vaccine is now the only one approved for those >...
Practice Alert
USPSTF update on sexually transmitted infections
Counseling—even if ≤ 30 minutes in a single session— can help curtail the spread of STIs, which are steadily increasing in incidence.
Practice Alert
Prospects and challenges for the upcoming influenza season
New vaccine and antiviral products are available, and additional vaccine contraindications are identified. The concurrence of influenza and SARS-...
Practice Alert
Taking steps to slow the upswing in oral and pharyngeal cancers
The CDC estimates that 70% of these cancers are caused by HPV. And yet, in 2018, only about two-thirds of adolescents had received 1 or more doses...
Practice Alert
USPSTF round-up
The Task Force now recommends that physicians take steps to prevent perinatal depression and has modified its recommendation on lead screening.
Practice Alert
ACIP vaccination update
Revisions for HepA concern homelessness, HIV, and vaccine catch-up. MenB booster is advised for those still at increased risk 1 year after...
Practice Alert
Pneumococcal conjugate vaccine update
ACIP no longer recommends routine use of PCV13 in immunocompetent adults ≥ 65 years. Three simple statements summarize guidance on intervals to...